Nuwellis, Inc. (NASDAQ:NUWE – Get Free Report) was up 2.4% during mid-day trading on Friday . The stock traded as high as $1.30 and last traded at $1.27. Approximately 126,201 shares were traded during mid-day trading, a decline of 87% from the average daily volume of 954,360 shares. The stock had previously closed at $1.24.
Nuwellis Price Performance
The firm has a 50-day simple moving average of $1.17 and a 200 day simple moving average of $1.54. The company has a market capitalization of $5.55 million, a PE ratio of -0.01 and a beta of 0.31.
Nuwellis (NASDAQ:NUWE – Get Free Report) last announced its earnings results on Monday, November 11th. The company reported $1.74 EPS for the quarter, beating the consensus estimate of ($0.88) by $2.62. The business had revenue of $2.37 million for the quarter, compared to the consensus estimate of $2.40 million. Nuwellis had a negative return on equity of 28,159.25% and a negative net margin of 169.54%. During the same period last year, the business posted ($63.29) EPS. Equities research analysts expect that Nuwellis, Inc. will post -8.17 EPS for the current fiscal year.
Nuwellis Company Profile
Nuwellis, Inc, a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter.
Featured Stories
- Five stocks we like better than Nuwellis
- Stock Analyst Ratings and Canadian Analyst Ratings
- IBM’s AI Bet Pays Off—What’s Next for Investors?
- Expert Stock Trading Psychology Tips
- 3 Reasons to Treat AMD’s Drop as an Entry Opportunity
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Qualcomm’s Post-Earnings Dip: A Prime Buying Opportunity?
Receive News & Ratings for Nuwellis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nuwellis and related companies with MarketBeat.com's FREE daily email newsletter.